Assess CVD risk in schizophrenia
26 October 2007
GPs have been urged to take more responsibility for the physical health of patients diagnosed with schizophrenia.
Metabolic and cardiovascular risk factors must be monitored in these patients, say a collection of advocacy groups including the National Obesity Forum.
Weight gain is a multi-pronged problem in schizophrenia. As well as issues over cardiovascular health, there are concerns that some patients discontinue antipsychotic drugs when they put on weight.
Although the management of severe psychiatric care should continue to be the preserve of specialist services, GPs should be getting more involved with day-to-day management of these patients, say the charities.
The GMS quality framework mental health domain has 23 points for giving patients with schizophrenia health promotion advice depending on their health status. But in the manifesto developed by the advocacy groups, GPs are urged to embrace this role 'enthusiastically'. It called on GPs to set up screening systems to help manage metabolic and cardiovascular risks.
This could lead to referring a patient back to secondary care for a review of their antipsychotic medication.
Dr Dave Tomson, a Tyneside GP with an interest in mental health, called for more flexible support from mental health services.
Additional Information

Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.







